Clinical Trial Update: A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions [Phase 4]

View source ↗

Summary

This Phase 4 trial compares a biodegradable-polymer sirolimus-eluting stent to a non-biodegradable polymer sirolimus-eluting stent in patients with de novo coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Excel Sirolimus Eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: JW Medical Systems Ltd | Conditions: Ischemia, Cardiac Death | Phase 4 | Status: UNKNOWN